About this trial
Hip fracture surgery is associated with significant postoperative pain and increased opioid requirements. Regional anesthesia techniques may improve analgesia and reduce opioid consumption. This prospective, randomized, double-blind, controlled trial aims to compare the postoperative analgesic efficacy of Quadro-Iliac Plane Block (QIPB), Suprainguinal Fascia Iliaca Block (SIFIB), and standard analgesia in patients undergoing hip fracture surgery under spinal anesthesia. The primary outcome is cumulative tramadol consumption during the first 24 postoperative hours. Secondary outcome measures include postoperative pain intensity, rescue analgesic requirement, incidence of postoperative nausea and vomiting, Quality of Recovery-15 (QoR-15) score, and patient satisfaction score.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adult patients aged 18 years or older
Patients scheduled for hip fracture surgery under spinal anesthesia
American Society of Anesthesiologists (ASA) physical status I-III
Provision of written informed consent
Disqualifiers
Refusal to participate
Contraindications to spinal anesthesia
Contraindications to regional anesthesia
Allergy to local anesthetics or study medications
Trial design
Parallel
Treatments tested in this trial
Quadro-Iliac Plane Block
Procedure/SurgeryUltrasound-guided quadro-iliac plane block will be performed following spinal anesthesia in patients undergoing hip fracture surgery. The block will be administered in addition to standard multimodal analgesia.
Suprainguinal Fascia Iliaca Block
Procedure/SurgeryUltrasound-guided suprainguinal fascia iliaca block will be performed following spinal anesthesia in patients undergoing hip fracture surgery. The block will be administered in addition to standard multimodal analgesia.
Standard Multimodal Analgesia
Other interventionPatients assigned to the control group will receive standard multimodal analgesia without a regional block following hip fracture surgery performed under spinal anesthesia.
Treatment groups
Trial outcomes
Primary outcomes
Cumulative Tramadol Consumption During the First 24 Postoperative Hours
The total amount of tramadol administered during the first 24 postoperative hours will be recorded and compared among the study groups.
Secondary outcomes
Postoperative Pain Intensity at Rest
Postoperative pain intensity at rest will be assessed using the 11-point Numeric Rating Scale (NRS), where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate greater pain intensity.
Time to First Rescue Analgesia
Time from completion of surgery to the first administration of rescue analgesia, measured in hours.
Rescue Analgesic Requirement
The proportion of patients requiring rescue analgesia during the first 24 hours after surgery.
Incidence of Postoperative Nausea and Vomiting
The incidence of postoperative nausea and/or vomiting during the first 24 hours after surgery will be recorded.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: